Comparing the therapeutic efficacy of oral minoxidil and oral finasteride in androgenic alopecia in males

Male pattern baldness (androgenic alopecia) is extremely common and can significantly affect self-esteem and wellbeing. It is caused by the effect of androgens (male hormones) on hair follicles over time. Two medications are commonly used to slow hair loss or promote regrowth: finasteride, which works by blocking the hormone signal, and minoxidil, which improves blood flow to hair follicles. Both are now available in oral tablet form, making them more convenient than topical treatments. This study is comparing the effectiveness of oral minoxidil (1.25 mg daily) versus oral finasteride (1 mg on alternate days) in men with early-to-moderate male pattern hair loss, over a six-month treatment period. Hair loss severity will be assessed using a standard photographic scale called the Hamilton-Norwood scale. You may be eligible if you are a male aged 18 to 45 with early-to-moderate androgenic alopecia (Hamilton-Norwood Stage I to IV), in generally good health, and have not received any hair loss treatment in the last three months. Patients with liver or kidney problems, hypersensitivity to either medication, or who are taking immunosuppressive therapy would not be eligible.